|4Feb 21, 7:32 PM ET

ENANTA PHARMACEUTICALS INC 4

4 · ENANTA PHARMACEUTICALS INC · Filed Feb 21, 2017

Insider Transaction Report

Form 4
Period: 2017-02-16
Transactions
  • Award

    Stock Option (right to buy)

    2017-02-16+7,5007,500 total
    Exercise: $29.02Exp: 2027-02-16Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 16, 2017), with the final monthly installment vesting at the 2018 annual meeting of stockholders.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT